$CVX

Walz Andrew Benjamin sold $3.4M of CVX

Walz Andrew Benjamin (President, DM&C) sold 16,800 shares of CHEVRON CORP (CVX) at $201.06 ($3.38M total) on 2026-08-17.

Original reporting
SEC EDGAR · Walz Andrew Benjamin
Published Aug 19, 2026, 9:23 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 19, 2026, 9:24 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CVX
Bearish
medium confidence
Mentioned
$CVX
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CVXBearishMed
01

Why it matters

The transaction provides fresh data on insider sentiment, potentially influencing short‑term trading decisions.

02

Market read

First public disclosure of a sizable insider sell at Chevron; may affect price action.

03

What to watch

No 10b5‑1 plan and small remaining stake could indicate personal liquidity needs rather than outlook.

Relevance 6/10Novelty 8/10Timing: post‑market 2026‑08‑17

Background

Form 4 filings disclose insider transactions; a $3.4M sale by a senior executive is noteworthy.

Company-level read

Ticker impact

$CVXBearishMedium confidence
Context

President Andrew Benjamin sold 16,800 shares for $3.38M, leaving a 14‑share stake.

Expected impact

Potential modest dip in near‑term trading as market digests insider sell.

Evidence & confidence

Sale size ($3.4M) is material for a senior executive; no 10b5‑1 plan suggests discretionary action.

Market effects

Energy sector may see slight bearish pressure as insider sell hints at confidence concerns.

U.S. energy stocks could experience minor pullback.

Limited; primarily affects CVX and comparable integrated oil majors.

Counterpoint

Insider may be diversifying; sale does not reflect company fundamentals.

Key entities

  • Andrew Benjamin Walz

    President, Downstream & Marketing & Commercial at Chevron.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CVXMed

HSBC raises Chevron stock price target to $250 on oil sensitivity

HSBC raised its price target on Chevron (CVX) to $250 from $218, maintaining a Buy rating. The firm cited Chevron's sensitivity to oil prices and revised earnings outlook. Chevron's 2026-2028 cash flow forecasts increased by 15%, 46%, and 23%, respectively. The stock trades at a P/E ratio of 19.8 with a 3.5% dividend yield. Chevron was involved in recent asset transactions in Angola and Namibia.

$CVXMed

Sullivan: Wall Street admits it doesn't know where oil is headed. There's one stock they do agree on

JPMorgan admits uncertainty about oil market's direction due to Iran conflict, with key economic indicators crossed. Analysts highlight Chevron (CVX) as a top pick, with Goldman Sachs raising its target to $240. BP (BP) is also noted for its evolving strategy and potential. Smaller cap Crescent Energy (CRGY) is recommended by Truist with a $19 target. Refiners like Valero (VLO), Marathon Petroleum (MPC), and others are near record highs.